These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18442742)

  • 1. Bisphosphonate related osteonecrosis of the palate: report of a case managed with free tissue transfer.
    Engroff SL; Coletti D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 May; 105(5):580-2. PubMed ID: 18442742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER; Basile JD
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconstruction of defects caused by bisphosphonate-induced osteonecrosis of the jaws.
    Marx RE
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):107-19. PubMed ID: 19371821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral bisphosphonate associated osteonecrosis of the jaws: three case reports.
    Malden NJ; Pai AY
    Br Dent J; 2007 Jul; 203(2):93-7. PubMed ID: 17660780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw.
    Wilde F; Heufelder M; Winter K; Hendricks J; Frerich B; Schramm A; Hemprich A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Feb; 111(2):153-63. PubMed ID: 20674411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate-induced osteonecrosis of the jaw.
    Sharma V; Nagaraj S; Choksey U; Hegde A; Samant R; Balakrishnan C
    J Assoc Physicians India; 2011 Aug; 59():516-7. PubMed ID: 21887911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases.
    Stanton DC; Balasanian E
    J Oral Maxillofac Surg; 2009 May; 67(5):943-50. PubMed ID: 19375001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical femoral fractures shortly after osteonecrosis of the jaw in a postmenopausal woman taking alendronate for osteoporosis.
    Chiu WY; Lee JJ; Tsai KS
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E723-6. PubMed ID: 23471975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral bisphosphonate-related osteonecrosis of the jaws: favorable outcome after bisphosphonate holiday.
    Kwon YD; Kim YR; Choi BJ; Lee DW; Kim DY
    Quintessence Int; 2009 Apr; 40(4):277-8. PubMed ID: 19417871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective study of two biochemical markers for the risk assessment of oral bisphosphonate-related osteonecrosis of the jaws: can they be utilized as risk markers?
    Kwon YD; Ohe JY; Kim DY; Chung DJ; Park YD
    Clin Oral Implants Res; 2011 Jan; 22(1):100-5. PubMed ID: 20946206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteonecrosis of the jaw and oral bisphosphonate treatment.
    Nase JB; Suzuki JB
    J Am Dent Assoc; 2006 Aug; 137(8):1115-9; quiz 1169-70. PubMed ID: 16873327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker.
    Pazianas M; Blumentals WA; Miller PD
    Osteoporos Int; 2008 Jun; 19(6):773-9. PubMed ID: 17999023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.
    Chiu CT; Chiang WF; Chuang CY; Chang SW
    J Oral Maxillofac Surg; 2010 May; 68(5):1055-63. PubMed ID: 20403529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study.
    Scoletta M; Arduino PG; Dalmasso P; Broccoletti R; Mozzati M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jul; 110(1):46-53. PubMed ID: 20452252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diphosphonate therapy and osteonecrosis of the jaw].
    Løkken P; Skoglund LA; Skjelbred P
    Tidsskr Nor Laegeforen; 2007 Aug; 127(15):1945-7. PubMed ID: 17700737
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw.
    Chu V; ;
    Hawaii Dent J; 2008; 39(5):9-12; quiz 17. PubMed ID: 19189512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry.
    Sedghizadeh PP; Stanley K; Caligiuri M; Hofkes S; Lowry B; Shuler CF
    J Am Dent Assoc; 2009 Jan; 140(1):61-6. PubMed ID: 19119168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Important aspects concerning alendronate-related osteonecrosis of the jaws: a literature review.
    Iglesias JE; Salum FG; Figueiredo MA; Cherubini K
    Gerodontology; 2015 Sep; 32(3):169-78. PubMed ID: 24256517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical concerns of alendronate use.
    Rutkowski JL; Johnson DA; Smith DM
    J Oral Maxillofac Surg; 2007 Feb; 65(2):363-4. PubMed ID: 17236956
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral bisphosphonate-related osteonecrosis of the jaws in rheumatoid arthritis patients: a critical discussion and two case reports.
    Conte-Neto N; Bastos AS; Spolidorio LC; Marcantonio RA; Marcantonio E
    Head Face Med; 2011 Apr; 7():7. PubMed ID: 21524309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.